MC1271A1 - Procede d'obtention d'un agent anti-tumoral - Google Patents

Procede d'obtention d'un agent anti-tumoral

Info

Publication number
MC1271A1
MC1271A1 MC791396A MC1396A MC1271A1 MC 1271 A1 MC1271 A1 MC 1271A1 MC 791396 A MC791396 A MC 791396A MC 1396 A MC1396 A MC 1396A MC 1271 A1 MC1271 A1 MC 1271A1
Authority
MC
Monaco
Prior art keywords
sarcosine
tumor
obtaining
tumor agent
inhibiting
Prior art date
Application number
MC791396A
Other languages
English (en)
French (fr)
Inventor
Osswald Hans
Youssef Mahmoud
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of MC1271A1 publication Critical patent/MC1271A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Surgical Instruments (AREA)
  • Toys (AREA)
  • Window Of Vehicle (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MC791396A 1978-07-20 1979-07-19 Procede d'obtention d'un agent anti-tumoral MC1271A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782832009 DE2832009A1 (de) 1978-07-20 1978-07-20 Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Publications (1)

Publication Number Publication Date
MC1271A1 true MC1271A1 (fr) 1980-05-23

Family

ID=6044955

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791396A MC1271A1 (fr) 1978-07-20 1979-07-19 Procede d'obtention d'un agent anti-tumoral

Country Status (13)

Country Link
US (1) US4766149A (da)
EP (1) EP0007597B1 (da)
JP (1) JPS5519270A (da)
AT (1) ATE11220T1 (da)
AU (1) AU529657B2 (da)
CA (1) CA1151065A (da)
DD (1) DD144864A5 (da)
DE (1) DE2832009A1 (da)
DK (1) DK305479A (da)
FI (1) FI792218A (da)
MC (1) MC1271A1 (da)
NO (1) NO792398L (da)
ZA (1) ZA793603B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
US4994492A (en) * 1989-01-09 1991-02-19 Foodscience Corporation Treatment of melanoma using N,N-dimethylglycine
US5676978A (en) * 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
DE4026184A1 (de) * 1990-08-18 1992-02-20 Henkel Kgaa Verfahren zur verminderung des restgehaltes an freiem alkylierungsmittel in waessrigen loesungen kationischer tenside
WO2004000042A2 (en) * 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US8697679B2 (en) * 2003-03-07 2014-04-15 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
EP1847274A1 (en) * 2006-04-21 2007-10-24 CIPROSA LLC - Corporate Creations Network, Inc. Association of phenylbutyrate, ATRA and cytidine and its use in anti-tumour therapy
EP3415910A1 (en) 2017-06-16 2018-12-19 Prevention Medicals s.r.o. A method of quantitative determination of sarcosine in a biological sample using anti-arcosine antibodies and peroxidase-active gold nanoparticles or quantum dots

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE553424C (de) * 1928-04-18 1932-06-27 Karl Luedecke Dr Verfahren zur Herstellung von Praeparaten, die das Wachstum von Geweben durch Verminderung der Teilungsfaehigkeit oder Aufloesung der wuchernden Zellen einschraenken
BE647556A (da) * 1964-05-06 1964-08-31
FR2085637A1 (fr) * 1970-04-15 1971-12-31 Etude Des Catalyseurs Soc D Composition pharmaceutique utilisable notamment contre l'asthenie
DE2211019C3 (de) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Geschmacksverbessernde Formulierungen oraler Penicilline

Also Published As

Publication number Publication date
ATE11220T1 (de) 1985-02-15
DK305479A (da) 1980-01-21
DD144864A5 (de) 1980-11-12
DE2832009C2 (da) 1988-07-28
EP0007597B1 (de) 1985-01-16
AU4907679A (en) 1980-01-24
AU529657B2 (en) 1983-06-16
DE2832009A1 (de) 1980-01-31
JPS5519270A (en) 1980-02-09
EP0007597A1 (de) 1980-02-06
ZA793603B (en) 1980-07-30
CA1151065A (en) 1983-08-02
NO792398L (no) 1980-01-22
FI792218A (fi) 1980-01-21
US4766149A (en) 1988-08-23

Similar Documents

Publication Publication Date Title
EG15458A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
ES8302681A1 (es) Un metodo para preparar derivados de fenilpiperazina
ES478047A1 (es) Procedimiento para la obtencion de acidos 4-piridon-3-car- boxilicos.
RO84151A (ro) Procedeu de preparare a unor derivati de penicilanoilo0imetilpenicilanat 1,1-dio0id
HU178663B (en) Fungicide compositions containing cyanopirrole derivatives as active agents,and process for producing the active agents
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
MC1271A1 (fr) Procede d'obtention d'un agent anti-tumoral
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
DE3164944D1 (en) 3,4,5-trihydroxypiperidine derivatives, process for their preparation, their use as medicines and in animal feeding
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
PT76844A (en) Ester of letronidazole with n,n-dimethylglycine and acid addition salt thereof
DE3066443D1 (en) Composition and method for inhibiting the formation of nitrosamine in organic amines by addition of 1,4-naphthoquinone, 1,4-naphthohydroquinone or alkyl derivatives thereof
FR2358388A1 (fr) Nouvelles 1,2,3,4-tetrahydro-4-imino-1-naphtylurees substituees, utiles notamment comme agents de croissance pour animaux, et leur procede de preparation
PT71308A (en) Process for the preparation of new 3,4,5-trihidrocy-piperidine derivatives with pharmaceutical and/or veterinary effect
BE882852A (fr) Procede de preparation d'une solution de gallium 68, sous forme ionique
GB1185618A (en) A Process for the Manufacture of Isoindole Derivatives
ES482541A1 (es) Un metodo de preparar imino-eteres.
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
ES8201531A1 (es) Procedimiento de preparar alcoxi propanolaminas
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES8105271A1 (es) Procedimiento para la obtencion de anilidas de acido ciclo- alcan (alquen) carboxilico,de efecto fungicida
ES8302682A1 (es) Un metodo de preparar derivados de fenil-piperazina
JPS53127829A (en) Agricultural and horticultural bactericide
SE8303378D0 (sv) Mineralsaltblandning
TW334424B (en) L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition

Legal Events

Date Code Title Description
YP Annual fee paid